Malaria is caused by infection with protozoan parasites of the genus, which is part of the phylum Apicomplexa. Most organisms in this phylum contain a relic plastid called the apicoplast. The apicoplast genome is replicated by a single DNA polymerase (apPOL), which is an attractive target for anti-malarial drugs. We screened small-molecule libraries (206,504 compounds) using a fluorescence-based high-throughput DNA polymerase assay. Dose/response analysis and counter-screening identified 186 specific apPOL inhibitors. Toxicity screening against human HepaRG human cells removed 84 compounds and the remaining were subjected to parasite killing assays using chloroquine resistant parasites. Nine compounds were potent inhibitors of parasite growth and may serve as lead compounds in efforts to discover novel malaria drugs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090415PMC
http://dx.doi.org/10.1080/14756366.2022.2070909DOI Listing

Publication Analysis

Top Keywords

dna polymerase
12
discovery small
4
small molecule
4
molecule inhibitors
4
inhibitors plasmodium
4
plasmodium falciparum
4
falciparum apicoplast
4
apicoplast dna
4
polymerase malaria
4
malaria caused
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!